ATE342367T1 - Verwendung von fusionsproteinen, deren n- terminaler teil aus einem hirudinderivat besteht, zur herstellung rekombinanter proteine durch sekretion durch hefen - Google Patents

Verwendung von fusionsproteinen, deren n- terminaler teil aus einem hirudinderivat besteht, zur herstellung rekombinanter proteine durch sekretion durch hefen

Info

Publication number
ATE342367T1
ATE342367T1 AT02719782T AT02719782T ATE342367T1 AT E342367 T1 ATE342367 T1 AT E342367T1 AT 02719782 T AT02719782 T AT 02719782T AT 02719782 T AT02719782 T AT 02719782T AT E342367 T1 ATE342367 T1 AT E342367T1
Authority
AT
Austria
Prior art keywords
nucleic acid
yeast
derivative
acid sequence
proteins
Prior art date
Application number
AT02719782T
Other languages
English (en)
Inventor
Paul Habermann
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE342367T1 publication Critical patent/ATE342367T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02719782T 2001-02-20 2002-02-08 Verwendung von fusionsproteinen, deren n- terminaler teil aus einem hirudinderivat besteht, zur herstellung rekombinanter proteine durch sekretion durch hefen ATE342367T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10108211A DE10108211A1 (de) 2001-02-20 2001-02-20 Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen

Publications (1)

Publication Number Publication Date
ATE342367T1 true ATE342367T1 (de) 2006-11-15

Family

ID=7674912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02719782T ATE342367T1 (de) 2001-02-20 2002-02-08 Verwendung von fusionsproteinen, deren n- terminaler teil aus einem hirudinderivat besteht, zur herstellung rekombinanter proteine durch sekretion durch hefen

Country Status (21)

Country Link
US (1) US20030176673A1 (de)
EP (1) EP1364032B1 (de)
JP (1) JP4199543B2 (de)
KR (1) KR100858833B1 (de)
CN (1) CN1279171C (de)
AT (1) ATE342367T1 (de)
AU (1) AU2002250903B2 (de)
BR (1) BR0207379A (de)
CA (1) CA2439042C (de)
CY (1) CY1106274T1 (de)
DE (2) DE10108211A1 (de)
DK (1) DK1364032T3 (de)
ES (1) ES2272696T3 (de)
IL (2) IL157416A0 (de)
MX (1) MXPA03007116A (de)
NO (1) NO331376B1 (de)
NZ (1) NZ527642A (de)
PE (1) PE20020857A1 (de)
PT (1) PT1364032E (de)
WO (1) WO2002070722A1 (de)
ZA (1) ZA200305868B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638618B2 (en) * 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DE102008025007A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
RU2524423C2 (ru) 2008-01-09 2014-07-27 Санофи-Авентис Дойчланд Гмбх Новые производные инсулина с чрезвычайно замедленным профилем время/действие
DE102008003566A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
KR20100111683A (ko) 2008-01-09 2010-10-15 사노피-아벤티스 도이칠란트 게엠베하 극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
PH12011502708B1 (en) 2009-07-06 2017-11-10 Sanofi Aventis Deutschland Insulin preparations containing methionine
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
US5705355A (en) * 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
US6875589B1 (en) * 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
DE69130872T2 (de) * 1990-11-08 1999-08-26 Japan Energy Corp. Sekretionsvektor, diesen enthaltene transformierte Mikroorganismen und Herstellung von Produkten durch obigen Mikroorganismus
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69722391T2 (de) * 1996-03-13 2004-04-22 Delta Biotechnology Ltd. Gärungs-steuerungssysteme
DE10033195A1 (de) * 2000-07-07 2002-03-21 Aventis Pharma Gmbh Bifunktionale Fusionsproteine aus Hirudin und TAP
US7202059B2 (en) * 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium

Also Published As

Publication number Publication date
HK1065068A1 (en) 2005-02-08
CA2439042C (en) 2013-06-18
KR100858833B1 (ko) 2008-09-17
DE60215315D1 (de) 2006-11-23
ZA200305868B (en) 2005-02-23
CN1279171C (zh) 2006-10-11
NZ527642A (en) 2005-03-24
DE60215315T2 (de) 2007-05-24
AU2002250903B2 (en) 2006-12-07
US20030176673A1 (en) 2003-09-18
PE20020857A1 (es) 2002-11-04
ES2272696T3 (es) 2007-05-01
CY1106274T1 (el) 2011-10-12
JP4199543B2 (ja) 2008-12-17
KR20030074841A (ko) 2003-09-19
MXPA03007116A (es) 2003-11-18
NO20033672L (no) 2003-10-17
DE10108211A1 (de) 2002-08-22
CN1526021A (zh) 2004-09-01
PT1364032E (pt) 2007-01-31
EP1364032B1 (de) 2006-10-11
IL157416A (en) 2009-08-03
CA2439042A1 (en) 2002-09-12
EP1364032A1 (de) 2003-11-26
DK1364032T3 (da) 2007-02-19
NO20033672D0 (no) 2003-08-19
IL157416A0 (en) 2004-03-28
NO331376B1 (no) 2011-12-12
BR0207379A (pt) 2004-06-15
WO2002070722A1 (en) 2002-09-12
JP2004518446A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
DE60215315D1 (de) Verwendung von fusionsproteinen, deren n-terminaler teil aus einem hirudinderivat besteht, zur herstellung rekombinanter proteine durch sekretion durch hefen
Vedvick et al. High-level secretion of biologically active aprotinin from the yeast Pichia pastoris
Lind et al. Novel forms of B‐domain‐deleted recombinant factor VIII molecules: construction and biochemical characterization
KR100227167B1 (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합단백질
Johansson et al. Surfactant protein B: disulfide bridges, structural properties and kringle similarities
AU619553B2 (en) Aprotinin analogues and a process for the production thereof
EP0399666A1 (de) N-terminale Fragmente von menschliches Serumalbumin enthaltenden Fusionsproteinen
EP0322094A1 (de) N-terminale Fragmente von menschlichem Serumalbumin
DK0755447T3 (da) Rekombinante proteiner af filamentøst hæmagglutinin fra Bordetella, især Bordetella Pertussis, fremgangsmåde til fremstilling heraf samt anvendelse heraf i fremstillingen af fremmede proteiner eller vacciner
KR880701105A (ko) 신규 응혈촉진 단백질
ATE527364T1 (de) Polypeptide erhaltend eine modifizierte menschliche serum-albumin sekretions-pre-sequenz mit erhöhtem ausscheidungsertrag
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
Yamada et al. Separation of recombinant human interleukin-2 and methionyl interleukin-2 produced in Escherichiacoli
DE60209883D1 (de) Übersekretierte peptide, deren herstellung, und gleichzeitige verbesserung der sekretierten form eines oder mehrerer anderer polypeptide
WO2006062398A3 (en) Methods for the production and secretion of modified peptides
Degryse et al. Addition of a dipeptide spacer significantly improves secretion of ovine trophoblast interferon in yeast
Olins et al. Phosphorylation of high‐and low‐molecular‐mass atrial natriuretic peptide analogs by cyclic AMP‐dependent protein kinase
Przysiecki et al. Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae
Okabayashi et al. Secretory production of recombinant urokinase-type plasminogen activator-annexin V chimeras in Pichia pastoris
Yu et al. Endogenous forms of fibrinogen in Hep G2 cells
Shi et al. Two-step ion-exchange chromatographic purification of recombinant hirudin-II and its C-terminal-truncated derivatives expressed in Pichia pastoris
Chow et al. Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion protein
CA2171557C (en) A secretion sequence for the production of a heterologous protein in yeast
Baron et al. Towards the structure of mosaic proteins: Use of protein expression and NMR techniques
Asakura et al. The enhancement of the extracellular carboxyl-terminal domain of human growth hormone receptor on growth hormone dependent responses of 3T3-F442A cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1364032

Country of ref document: EP